Trial · NCT03065127
Investigating Therapies for Freezing of Gait
NCT03065127, Not applicable, Unknown, Sun Life Financial Movement Disorders Research and Rehabilitation Centre
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Investigating Therapies for Freezing of Gait. Trials, record NCT03065127. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03065127
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Investigating Therapies for Freezing of Gait
- NCT number
- NCT03065127
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 17 participants, actual
- Lead sponsor
- Sun Life Financial Movement Disorders Research and Rehabilitation Centre
- Conditions
- Parkinson Disease, Gait Disorders, Neurologic
- Interventions
- Cognitive Training, Cognitive Behavioural Therapy, Proprioceptive Training
- First posted
- 2017-02-27
- Last updated
- 2017-04-25
Source ClinicalTrials.gov
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Gait Assessment | Change from Baseline at 4 weeks of first treatment phase | Participants will walk approximately 9.75 metres for 12 trials. Recording of kinematic data will be done with eight Optotrak® cameras (Northern Digital, NDI, Waterloo, Ontario). Spatiotemporal gait parameters will be analyzed from this assessment. |
| Primary | Gait Assessment | Change from Baseline at 4 weeks of second treatment phase | Participants will walk approximately 9.75 metres for 12 trials. Recording of kinematic data will be done with eight Optotrak® cameras (Northern Digital, NDI, Waterloo, Ontario). Spatiotemporal gait parameters will be analyzed from this assessment. |
| Primary | Gait Assessment | Change from Baseline at 4 weeks of third treatment phase | Participants will walk approximately 9.75 metres for 12 trials. Recording of kinematic data will be done with eight Optotrak® cameras (Northern Digital, NDI, Waterloo, Ontario). Spatiotemporal gait parameters will be analyzed from this assessment. |
| Secondary | Stroop Test | Pre-intervention and Post-intervention at week 4 of first treatment phase | This test assesses inhibitory control and will be administered in a paper-based format. |
| Secondary | Trail-making test | Pre-intervention and Post-intervention at week 4 of first treatment phase | This will also be administered in a paper-based format. This test will assess visuospatial function and set-shifting ability. |
| Secondary | Stroop Test | Pre-intervention and Post-intervention at week 4 of second treatment phase | This test assesses inhibitory control and will be administered in a paper-based format. |
| Secondary | Trail-making test | Pre-intervention and Post-intervention at week 4 of second treatment phase | This will also be administered in a paper-based format. This test will assess visuospatial function and set-shifting ability. |
| Secondary | Stroop Test | Pre-intervention and Post-intervention at week 4 of third treatment phase | This test assesses inhibitory control and will be administered in a paper-based format. |
| Secondary | Trail-making test | Pre-intervention and Post-intervention at week 4 of third treatment phase | This will also be administered in a paper-based format. This test will assess visuospatial function and set-shifting ability. |
| Secondary | Passive Joint Angle Matching | Pre-intervention and Post-intervention at week 4 of first treatment phase | This task will be assessed in order to evaluate proprioceptive functioning. |
1 to 10 of 21Source ClinicalTrials.gov
See all 21 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 33559531 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03065127
GET https://conductscience.org/api/trials/v1/NCT03065127/registered?page=2